Loomis, Sayles & Company
NEO icon

Loomis, Sayles & Company’s NeoGenomics NEO Stock Holding History

Loomis, Sayles & Company’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4M Buy
1,945,388
+314,253
+19% +$3.31M 0.02% 286
2025
Q4 		$19.2M Buy
+1,631,135
New +$17.6M 0.02% 241
2025
Q2 		– Sell
-1,752,681
Closed -$16.6M – 775
2025
Q1 		$16.6M Sell
1,752,681
-39,111
-2% -$488K 0.02% 267
2024
Q4 		$29.5M Buy
1,791,792
+584,502
+48% +$9.08M 0.04% 201
2024
Q3 		$17.8M Buy
+1,207,290
New +$18.9M 0.02% 274
2022
Q1 		– Sell
-707,195
Closed -$24.1M – 1033
2021
Q4 		$24.1M Sell
707,195
-315,745
-31% -$12.4M 0.03% 282
2021
Q3 		$49.3M Sell
1,022,940
-15,855
-2% -$734K 0.06% 146
2021
Q2 		$46.9M Sell
1,038,795
-202,902
-16% -$8.99M 0.06% 163
2021
Q1 		$59.9M Sell
1,241,697
-4,131
-0.3% -$215K 0.08% 112
2020
Q4 		$67.1M Sell
1,245,828
-7,087
-0.6% -$320K 0.09% 94
2020
Q3 		$46.2M Buy
1,252,915
+23,787
+2% +$884K 0.07% 118
2020
Q2 		$38.1M Buy
1,229,128
+106,650
+10% +$2.96M 0.06% 121
2020
Q1 		$31M Buy
1,122,478
+121,865
+12% +$3.65M 0.06% 113
2019
Q4 		$29.3M Sell
1,000,613
-3,216
-0.3% -$76.6K 0.05% 152
2019
Q3 		$19.2M Sell
1,003,829
-130,413
-11% -$3.06M 0.04% 218
2019
Q2 		$24.9M Buy
1,134,242
+55,542
+5% +$1.22M 0.05% 178
2019
Q1 		$22.1M Sell
1,078,700
-52,466
-5% -$912K 0.04% 187
2018
Q4 		$14.3M Buy
+1,131,166
New +$16.9M 0.03% 232
2016
Q4 		– Sell
-608
Closed -$5K – 1077
2016
Q3 		$5K Hold
608
– – ﹤0.01% 875
2016
Q2 		$5K Hold
608
– – ﹤0.01% 853
2016
Q1 		$4K Buy
+608
New +$4K ﹤0.01% 957

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Loomis, Sayles & Company's NEO Position: Q1 2026 in Review

Loomis, Sayles & Company increased its NeoGenomics (NEO) stake by 19% in Q1 2026, buying an estimated $3.31M and bringing the position to 1,945,388 shares worth $14.4M. The position accounts for 0.02% of the portfolio, ranked #286.

Loomis, Sayles & Company first reported a position in NEO in Q1 2016 and has held it in 21 quarters since. The position peaked at $67.1M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Loomis, Sayles & Company held 1,945,388 shares of NeoGenomics worth $14.4M as of Q1 2026.
  • Loomis, Sayles & Company bought 314,253 NeoGenomics shares in Q1 2026, an estimated $3.31M.
  • NeoGenomics made up 0.02% of Loomis, Sayles & Company's portfolio in Q1 2026, its #286 holding.
  • Loomis, Sayles & Company first reported a position in NeoGenomics in Q1 2016 and has held it in 21 quarters since.
  • Loomis, Sayles & Company's NeoGenomics position peaked at $67.1M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.